Anaphylactoid reaction to ranitidine administered prophylactically in labour is a rare occurrence. We report a case and its subsequent investigation.
CASE REPORT
A 19-year-old primigravida at term was transferred from her local hospital to the tertiary care facility following a prolonged labour (24 hours) with meconium-stained liquor. She was admitted to the labour ward and found to be dehydrated. Vaginal examination was performed and the cervix was found to be 4cm dilated and the position occipito-posterior.
She was treated with intravenous rehydration and Syntocinon augmentation, with a lumbar epidural for pain relief. The foetus was monitored via a scalp electrode.
Five hours later the foetus developed bradycardia and it was thought lower uterine segment caesarian section (LUSCS) would be required. She was given ranitidine 50mg (Zantac) via slow IV push as part of the standard protocol for emergency LUSCS.
She immediately complained of a horrible taste in the mouth, of difficulty breathing and speaking, and became wheezy. Within several minutes she developed facial and periorbital oedema. Heart rate was 120 bpm and blood pressure 110/70 mm Hg. She was given oxygen via facemask at 4 litres/min, promethazine 25mg IV and hydrocortisone 100mg IV.
Pulse oximetry remained at 94070 despite administration of oxygen at 411min via a Hudson mask, but blood pressure and pulse remained stable. Adrenaline was not given initially due to the pre-existing foetal distress.
The foetal bradycardia resolved spontaneously and labour continued. She continued to receive oxygen as labour progressed and four hours later a live male infant was delivered (Apgar score 9 at 1 minute, 10 at 5 minutes).
The difficulty with breathing and arterial desaturation had resolved by the time of delivery. The facial oedema gradually resolved over the next three days and no further intervention was required.
She was referred to the Anaesthetic Department for investigation of probable allergy to ranitidine.
Despite the fairly convincing time sequence indicating an anaphylactoid reaction to ranitidine, we were interested to see if we could demonstrate a positive skin test. A review of the literature did not yield details of control groups for skin testing of the H, blockers.
A control group of twenty volunteers from the Anaesthetic Department were tested with 1:1000 dilution of ranitidine according to Dr Fisher's criteria I. No wheal or flare was evident at 10 or 30 minutes in all 20 controls.
We also tested 13 volunteers to omeprazole following the same protocol. At 1:1000 dilution there were no positive responses. Two volunteers in each group were inadvertently given 1:100 dilution and all four demonstrated a positive wheal and flare. They all had a negative response to the corresponding 1:1000 dilution.
The patient presented for skin testing at six weeks post partum and demonstrated a convincing positive result to ranitidine at 1:1000 dilution (wheal 9mm, flare 59mm at 30 minutes).
It was considered important to determine whether this was due to the 'active ingredient' ranitidine or to the additives. After liaison with the drug company she was retested four months later and showed a convincing positive to pure ranitidine and no response to the additives (buffer solutions). She was also tested to omeprazole 1:1000, which gave a negative result.
DISCUSSION
Anaphylactoid reaction to ranitidine has been reported only rarely in obstetric patients 2.3 and, as in this patient, can occur even without prior exposure to the drug. The reaction has involved dyspnoea, stridor, facial and lingual oedema. In this case symptoms responded to HI blocker and corti co steroids were given to attenuate the ongoing reaction.
This patient did not require further anaesthesia for delivery. However, had she required an operative delivery it would have been necessary to decide whether a regional or general anaesthetic was appropriate. In either case, cardiovascular instability, an oedematous airway and difficult intubation would have had to be considered.
This case raises the question of routine H, blockers for emergency caesarian section. There is little evidence to show that, when given immediately, prior to surgery, Anaesthesia and Intensive Care. Vol. 21. No. 5, October. 1993 they are beneficial in reducing gastric pH and volume to cover surgery. They do provide protection in the postoperative recovery phase. Although a reaction is rare, when it does occur this is in the context of an already compromised foetus, and it may have disastrous consequences.
Only one case of cross-reactivity with H, receptor antagonists has been reported involving ranitidine, famotidine and nizatidine. 4 Omeprazole has been trialled in obstetric patients 5 and found to be effective in reducing intragastric volume and acidity to acceptable levels. Our patient exhibited a negative skin test to omeprazole, which could be used with caution if a future need arises for acute reduction in gastric acid production.
